A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas
Clinical trial NCT02401048 · COMPLETED
Trial details
- NCT number
- NCT02401048
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-11-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.